Keyword Connections

•  A. Brill
•  Albert Reynolds
•  Alexander Zaika
•  Alicia Beeghly-Fadiel
•  Alissa Weaver
•  Allie Greenplate
•  Andries Zijlstra
•  Anna Means
•  Ann Richmond
•  Aron Parekh
•  Austin Kirschner
•  Barbara Fingleton
•  Barbara Murphy
•  Barbara Schneider
•  B. Paudel
•  Bryan Venters
•  Carlos Arteaga
•  Chin Chiang
•  Christopher Williams
•  Claudia Andl
•  C. Quarles
•  David Wooten
•  Dayanidhi Raman
•  Dineo Khabele
•  Eduard Chekmenev
•  Eric Gamazon
•  Eric Grogan
•  Ethan Lee
•  Eunyoung Choi
•  Ginger Holt
•  Gregor Neuert
•  Harold "Bo" Lovvorn
•  H. Ruley

•  Ingrid Mayer
•  Irina Kaverina
•  James Goldenring
•  James Patton
•  Jeffrey Sosman
•  Jennifer Noto
•  Jialiang Wang
•  Jin Chen
•  John Gore
•  Jonathan Irish
•  Julie Sterling
•  Keith Wilson
•  Ken Lau
•  Krystle Lang Kuhs
•  Kyle Weaver
•  Leonard Harris
•  Leon Raskin
•  Linda Sealy
•  Linda W. Horton
•  Maciej Buchowski
•  Mark de Caestecker
•  Mary Washington
•  Meira Epplein
•  Michael Freeman
•  Michael VanSaun
•  Michelle Armstrong
•  Ming-Zhi Zhang
•  Nagaraj Nagathihalli
•  Natasha Deane
•  Neeraja Peterson
•  Oliver McDonald
•  Oriana Hawkins
•  Otis Rickman

•  Pamela Hull
•  Pampee Young
•  Rebecca Ihrie
•  Richard Breyer
•  Richard Peek
•  Robbert Slebos
•  Robert Beauchamp
•  Robert Coffey
•  Robert Matusik
•  Ronald Alvarez
•  Sandra Zinkel
•  Sarah Nechuta
•  Serk In Park
•  Simon Hayward
•  Stacey Huppert
•  Stephen Fesik
•  Stephen Hann
•  Sudan Loganathan
•  Taewan Kim
•  Tammy Sobolik
•  Thomas Andl
•  Thomas Yankeelov
•  Timothy Cover
•  Vikrant Sahasrabuddhe
•  Vito Quaranta
•  Volker Haase
•  Wael El-Rifai
•  Walter Chazin
•  Wellington Pham
•  W. Jerome
•  W. Rathmell
•  Xiangli Yang
•  Xiao Shu

Resources

• Expedited Phenotyping

Communities

• Beauchamp Laboratory
• Center for Mucosal Inflammation and Cancer
• Coffey Lab
• de Caestecker Lab
• Goldenring Lab
• HPV-Associated Cancer ConsorTIum at VandErbilt
• Ihrie Lab
• Irish Lab
• Matusik Lab
• Quaranta Lab
• Richard Ho Laboratory
• Richmond Lab
• Young Lab
• Yull Lab
• Zinkel Lab

Publications

• Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
  Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF, IMPACT Study Investigators
  (2010) N Engl J Med 363: 411-22
• Improved survival with ipilimumab in patients with metastatic melanoma.
  Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ
  (2010) N Engl J Med 363: 711-23
• Genomic Classification of Cutaneous Melanoma.
  Cancer Genome Atlas Network
  (2015) Cell 161: 1681-96
• Integrated genomic characterization of papillary thyroid carcinoma.
  Cancer Genome Atlas Research Network
  (2014) Cell 159: 676-90
• Consensus on biomarkers for neuroendocrine tumour disease.
  Oberg K, Modlin IM, De Herder W, Pavel M, Klimstra D, Frilling A, Metz DC, Heaney A, Kwekkeboom D, Strosberg J, Meyer T, Moss SF, Washington K, Wolin E, Liu E, Goldenring J
  (2015) Lancet Oncol 16: e435-e446
• When will melanoma vaccines be proven effective?
  Sosman JA, Weeraratna AT, Sondak VK
  (2004) J Clin Oncol 22: 387-9
• High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.
  Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS, Rao U
  (2001) J Clin Oncol 19: 2370-80
• Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.
  Sosman JA, Unger JM, Liu PY, Flaherty LE, Park MS, Kempf RA, Thompson JA, Terasaki PI, Sondak VK, Southwest Oncology Group
  (2002) J Clin Oncol 20: 2067-75
• Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
  Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, O'Reilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J
  (2009) J Clin Oncol 27: 5660-9
• Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
  Sosman JA, Carrillo C, Urba WJ, Flaherty L, Atkins MB, Clark JI, Dutcher J, Margolin KA, Mier J, Gollob J, Kirkwood JM, Panka DJ, Crosby NA, O'Boyle K, LaFleur B, Ernstoff MS
  (2008) J Clin Oncol 26: 2292-8
• Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.
  Sondak VK, Liu PY, Tuthill RJ, Kempf RA, Unger JM, Sosman JA, Thompson JA, Weiss GR, Redman BG, Jakowatz JG, Noyes RD, Flaherty LE
  (2002) J Clin Oncol 20: 2058-66
• Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.
  Mountz JM, Yankeelov TE, Rubin DL, Buatti JM, Erikson BJ, Fennessy FM, Gillies RJ, Huang W, Jacobs MA, Kinahan PE, Laymon CM, Linden HM, Mankoff DA, Schwartz LH, Shim H, Wahl RL
  (2014) J Clin Oncol 32: 2115-6
• Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers.
  Epplein M, Koon KP, Ramsey SD, Potter JD
  (2005) J Clin Oncol 23: 4713-8
• Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention.
  Armenian SH, Armstrong GT, Aune G, Chow EJ, Ehrhardt MJ, Ky B, Moslehi J, Mulrooney DA, Nathan PC, Ryan TD, van der Pal HJ, van Dalen EC, Kremer LCM
  (2018) J Clin Oncol 36: 2135-2144
• Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
  Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N, American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association
  (2010) Circulation 121: 833-40
• Grounding Cardio-Oncology in Basic and Clinical Science.
  Moslehi J, Amgalan D, Kitsis RN
  (2017) Circulation 136: 3-5
• Treatment of HER2-positive breast cancer: current status and future perspectives.
  Arteaga CL, Sliwkowski MX, Osborne CK, Perez EA, Puglisi F, Gianni L
  (2011) Nat Rev Clin Oncol 9: 16-32
• Lung cancer screening and smoking cessation: a teachable moment?
  Deppen SA, Grogan EL, Aldrich MC, Massion PP
  (2014) J Natl Cancer Inst 106: dju122
• Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.
  Ajona D, Pajares MJ, Corrales L, Perez-Gracia JL, Agorreta J, Lozano MD, Torre W, Massion PP, de-Torres JP, Jantus-Lewintre E, Camps C, Zulueta JJ, Montuenga LM, Pio R
  (2013) J Natl Cancer Inst 105: 1385-93
• No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
  Mahmoud R, Shah SC, Ten Hove JR, Torres J, Mooiweer E, Castaneda D, Glass J, Elman J, Kumar A, Axelrad J, Ullman T, Colombel JF, Oldenburg B, Itzkowitz SH, Dutch Initiative on Crohn and Colitis
  (2019) Gastroenterology 156: 1333-1344.e3
• Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.
  Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT
  (2010) Gastroenterology 138: 949-57.e1-7
• Genetic Risk Score Is Associated With Prevalence of Advanced Neoplasms in a Colorectal Cancer Screening Population.
  Weigl K, Thomsen H, Balavarca Y, Hellwege JN, Shrubsole MJ, Brenner H
  (2018) Gastroenterology 155: 88-98.e10
• Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.
  Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC
  (2018) Gastroenterology 155: 648-660
• Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.
  Maldonado F, Duan F, Raghunath SM, Rajagopalan S, Karwoski RA, Garg K, Greco E, Nath H, Robb RA, Bartholmai BJ, Peikert T
  (2015) Am J Respir Crit Care Med 192: 737-44
• Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.
  Mazzone PJ, Sears CR, Arenberg DA, Gaga M, Gould MK, Massion PP, Nair VS, Powell CA, Silvestri GA, Vachani A, Wiener RS, ATS Assembly on Thoracic Oncology
  (2017) Am J Respir Crit Care Med 196: e15-e29
• Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin.
  Erdogan B, Ao M, White LM, Means AL, Brewer BM, Yang L, Washington MK, Shi C, Franco OE, Weaver AM, Hayward SW, Li D, Webb DJ
  (2017) J Cell Biol 216: 3799-3816
• Overdiagnosis and overtreatment of prostate cancer.
  Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R
  (2014) Eur Urol 65: 1046-55
• Editorial comment on: Vaccine therapy in patients with renal cell carcinoma.
  Clark PE
  (2009) Eur Urol 55: 1343-4
• Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.
  Ellis MJ, Gillette M, Carr SA, Paulovich AG, Smith RD, Rodland KK, Townsend RR, Kinsinger C, Mesri M, Rodriguez H, Liebler DC, Clinical Proteomic Tumor Analysis Consortium (CPTAC)
  (2013) Cancer Discov 3: 1108-12
• Versatile prostate cancer treatment with inducible caspase and interleukin-12.
  Nikitina EY, Desai SA, Zhao X, Song W, Luo AZ, Gangula RD, Slawin KM, Spencer DM
  (2005) Cancer Res 65: 4309-19
• Lung cancer diagnosis from proteomic analysis of preinvasive lesions.
  Rahman SM, Gonzalez AL, Li M, Seeley EH, Zimmerman LJ, Zhang XJ, Manier ML, Olson SJ, Shah RN, Miller AN, Putnam JB, Miller YE, Franklin WA, Blot WJ, Carbone DP, Shyr Y, Caprioli RM, Massion PP
  (2011) Cancer Res 71: 3009-17
• Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines.
  Pulaski BA, Ostrand-Rosenberg S
  (1998) Cancer Res 58: 1486-93
• Electrochemical sensor for multiplex biomarkers detection.
  Wei F, Patel P, Liao W, Chaudhry K, Zhang L, Arellano-Garcia M, Hu S, Elashoff D, Zhou H, Shukla S, Shah F, Ho CM, Wong DT
  (2009) Clin Cancer Res 15: 4446-52
• Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.
  Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB, Platinum Study Group
  (2017) Clin Cancer Res 23: 5757-5768
• Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine.
  Sondak VK, Sosman JA
  (2003) Semin Cancer Biol 13: 409-15
• Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry.
  Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT
  (2012) Mol Cell Proteomics 11: M111.012112
• Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.
  Rodriguez H, Tezak Z, Mesri M, Carr SA, Liebler DC, Fisher SJ, Tempst P, Hiltke T, Kessler LG, Kinsinger CR, Philip R, Ransohoff DF, Skates SJ, Regnier FE, Anderson NL, Mansfield E, Workshop Participants
  (2010) Clin Chem 56: 237-43
• Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.
  Ausch C, Kim YH, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich J, Grady WM
  (2009) Clin Chem 55: 1559-63
• Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
  Hoshimoto S, Faries MB, Morton DL, Shingai T, Kuo C, Wang HJ, Elashoff R, Mozzillo N, Kelley MC, Thompson JF, Lee JE, Hoon DS
  (2012) Ann Surg 255: 357-62
• Ratio of IgG:IgM antibodies to sialyl Lewis(x) and GM3 correlates with tumor growth after immunization with melanoma-cell vaccine with different adjuvants in mice.
  Ravindranath MH, Kelley MC, Jones RC, Amiri AA, Bauer PM, Morton DL
  (1998) Int J Cancer 75: 117-24